Biogen Idec and Samsung Bioepis announce agreement to market anti-TNF biosimilar product candidates in Europe
Biogen Idec opts-in to commercialization opportunity with joint venture partner...
17 December 2013 | By Biogen Idec
Biogen Idec opts-in to commercialization opportunity with joint venture partner...